- Home
- INBX vs TWN Comparison
INBX vs TWN Comparison
Compare INBX & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- TWN
- Stock Information
- Founded
- INBX 2010
- TWN 1986
- Country
- INBX United States
- TWN Hong Kong
- Employees
- INBX N/A
- TWN N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- INBX Health Care
- TWN Finance
- Exchange
- INBX Nasdaq
- TWN Nasdaq
- Market Cap
- INBX 168.1M
- TWN 193.5M
- IPO Year
- INBX 2020
- TWN N/A
- Fundamental
- Price
- INBX $11.86
- TWN $29.93
- Analyst Decision
- INBX Hold
- TWN
- Analyst Count
- INBX 1
- TWN 0
- Target Price
- INBX N/A
- TWN N/A
- AVG Volume (30 Days)
- INBX 142.0K
- TWN 20.1K
- Earning Date
- INBX 05-08-2025
- TWN 01-01-0001
- Dividend Yield
- INBX 7.26%
- TWN 1.10%
- EPS Growth
- INBX N/A
- TWN N/A
- EPS
- INBX 112.62
- TWN N/A
- Revenue
- INBX $200,000.00
- TWN N/A
- Revenue This Year
- INBX N/A
- TWN N/A
- Revenue Next Year
- INBX N/A
- TWN N/A
- P/E Ratio
- INBX $0.10
- TWN N/A
- Revenue Growth
- INBX N/A
- TWN N/A
- 52 Week Low
- INBX $10.80
- TWN $25.22
- 52 Week High
- INBX $18.95
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- INBX 41.57
- TWN 34.43
- Support Level
- INBX $11.22
- TWN $29.43
- Resistance Level
- INBX $12.06
- TWN $32.16
- Average True Range (ATR)
- INBX 0.95
- TWN 1.59
- MACD
- INBX -0.11
- TWN 0.13
- Stochastic Oscillator
- INBX 32.99
- TWN 42.15
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.